The Early Drug Development Summit 2012

The Early Drug Development Summit 2012 covers topics such as:

• Toxicology & Safety
  
  • Applying Predictive and Simulation Modelling in Preclinical Development
  • Using Predictive Pharmaceutical Modelling to Predict a Compound’s SAR Profile
• Maximising Drug Investments
  
  • Optimising Decision Making in Early Development- Prioritising the Best Investments
  • Maximising Investment to Reduce Risk and Cost of Early Development
• Biomarkers
  
  • Utilising Biomarkers to Bridge the Gap Between Preclinical and Clinical Trials
  • Accelerating Clinical Trials Using Predictive Humanised Animal Models

The Early Drug Development Summit 2012 brings together Directors, VPs and Heads of: Drug Development, Clinical Development, Biomarker development, Early Development, Clinical Toxicology, Head of Toxicology, Clinical Trial Management, Head of R&D, Clinical Oncology, Drug Safety Translational Research, Analytical R&D, Process Chemistry, Safety Assessment, Drug Metabolism and Pharmacokinetics (DMPK), Bioanalytical, Safety Pharmacology and Clinical Pharmacology.